Actually the advantage of Ibsrela is, that it's not a secretagogue but has a very different mode of action. The company is not competing with the secretagogues but target the patients who are not well managed by Trulance or Linzess or other drugs.After two+ years of being FDA approved. They are finally bringing it to market. I believe the reason why it took this long is because they wanted to market tenapanor to treat another disease that would have been more profitable. I'm not sure why they shifted gears, perhaps the other market didn't work out for them.
From what I've read, it's basically another secretatatogue like Linzess or Trulance. My hope is that it will be less severe and cause less D while still being an effective treatment for the C.
Ardelyx Launching IBSRELA® Second Quarter of 2022
/PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a specialty biopharmaceutical company founded with a mission to discover, develop and commercialize innovative...www.prnewswire.com
1 - 1 of 1 Posts
1 - 1 of 1 Posts
- This is an older thread, you may not receive a response, and could be reviving an old thread. Please consider creating a new thread.
Irritable Bowel Syndrome and Digestive Health Support Forum
A forum community dedicated to Irritable Bowel Syndrome and Digestive Health Support. Come join the discussion about treatment, diet, health, lifestyles, spirituality, medication, research, recovery, and more!
Full Forum Listing
Recommended Communities
Join now to ask and comment!
